Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Zhu C, Vukusic S, Kalincik T, Mathey G, Kermode AG, Maillart E, Lechner-Scott J, Le Page E, Roos I, Ciron J, et al.

J Neurol Neurosurg Psychiatry. 2026 Aug 14. PMID: 42601218. Abstract